United States Biotechnology & Medical Research

Tyme Technologies Inc (TYME)

Track

Ticker: TYME Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tyme Technologies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 7 Sep 2022
Value US$1,824,123.08 | Price 202.57 | Shares 4,024 (+28.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-07 2022-09-07 S Sale
3.7
Demurjian Michael
Large shareholder
4,024 +28.2%
202.57
US$1,824,123 		4,024 +28.2% 202.57 US$1,824,123
2022-09-07 2022-09-06 S Sale
3.7
Demurjian Michael
Large shareholder
71,989 -27.2%
278.76
US$1,087,877 		71,989 -27.2% 278.76 US$1,087,877
2022-08-23 2022-08-23 S Sale
3.7
Demurjian Michael
Large shareholder
58,794 +19.1%
133.76
US$2,463,303 		58,794 +19.1% 133.76 US$2,463,303
2022-08-23 2022-08-22 S Sale
3.7
Demurjian Michael
Large shareholder
80,000 -0.4%
0.29
US$23,432 		80,000 -0.4% 0.29 US$23,432
2022-07-26 2022-07-26 S Sale
3.7
Demurjian Michael
Large shareholder
70,000 -0.3%
0.29
US$20,636 		70,000 -0.3% 0.29 US$20,636
2022-07-26 2022-07-25 S Sale
3.7
Demurjian Michael
Large shareholder
70,000 -0.3%
0.29
US$20,419 		70,000 -0.3% 0.29 US$20,419
2022-07-12 2022-07-12 S Sale
3.7
Demurjian Michael
Large shareholder
70,000 -0.3%
0.29
US$20,048 		70,000 -0.3% 0.29 US$20,048
2022-07-12 2022-07-11 S Sale
3.7
Demurjian Michael
Large shareholder
70,000 -0.3%
0.29
US$20,020 		70,000 -0.3% 0.29 US$20,020
2022-06-28 2022-06-28 S Sale
3.7
Demurjian Michael
Large shareholder
60,000 -0.3%
0.27
US$16,074 		60,000 -0.3% 0.27 US$16,074
2022-06-27 2022-06-27 S Sale
3.7
Demurjian Michael
Large shareholder
60,000 -0.3%
0.26
US$15,732 		60,000 -0.3% 0.26 US$15,732
2022-06-23 2022-06-22 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.27
US$21,094 		78,125 -0.4% 0.27 US$21,094
2022-06-23 2022-06-21 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.26
US$20,312 		78,125 -0.4% 0.26 US$20,312
2022-06-15 2022-06-15 S Sale
3.7
Demurjian Michael
Large shareholder
60,000 -0.3%
0.26
US$15,720 		60,000 -0.3% 0.26 US$15,720
2022-06-15 2022-06-14 S Sale
3.7
Demurjian Michael
Large shareholder
60,000 -0.3%
0.25
US$15,054 		60,000 -0.3% 0.25 US$15,054
2022-06-10 2022-06-09 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.27
US$21,094 		78,125 -0.4% 0.27 US$21,094
2022-06-10 2022-06-08 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.27
US$21,094 		78,125 -0.4% 0.27 US$21,094
2022-06-02 2022-06-01 S Sale
3.7
Demurjian Michael
Large shareholder
66,903 -0.3%
0.25
US$16,799 		66,903 -0.3% 0.25 US$16,799
2022-06-02 2022-05-31 S Sale
3.7
Demurjian Michael
Large shareholder
53,097 -0.2%
0.25
US$13,306 		53,097 -0.2% 0.25 US$13,306
2022-05-27 2022-05-26 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.24
US$18,750 		78,125 -0.4% 0.24 US$18,750
2022-05-27 2022-05-25 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.24
US$18,750 		78,125 -0.4% 0.24 US$18,750
2022-05-17 2022-05-17 S Sale
3.7
Demurjian Michael
Large shareholder
50,000 -0.2%
0.25
US$12,540 		50,000 -0.2% 0.25 US$12,540
2022-05-17 2022-05-16 S Sale
3.7
Demurjian Michael
Large shareholder
50,000 -0.2%
0.25
US$12,505 		50,000 -0.2% 0.25 US$12,505
2022-05-11 2022-05-10 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.28
US$21,875 		78,125 -0.4% 0.28 US$21,875
2022-05-11 2022-05-09 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.31
US$24,219 		78,125 -0.4% 0.31 US$24,219
2022-05-03 2022-05-03 S Sale
3.7
Demurjian Michael
Large shareholder
50,000 -0.2%
0.32
US$16,170 		50,000 -0.2% 0.32 US$16,170
2022-05-03 2022-05-02 S Sale
3.7
Demurjian Michael
Large shareholder
50,000 -0.2%
0.31
US$15,695 		50,000 -0.2% 0.31 US$15,695
2022-04-29 2022-04-28 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.32
US$25,000 		78,125 -0.4% 0.32 US$25,000
2022-04-29 2022-04-27 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.32
US$25,000 		78,125 -0.4% 0.32 US$25,000
2022-04-21 2022-04-20 S Sale
3.7
Demurjian Michael
Large shareholder
40,000 -0.2%
0.32
US$12,952 		40,000 -0.2% 0.32 US$12,952
2022-04-21 2022-04-19 S Sale
3.7
Demurjian Michael
Large shareholder
40,000 -0.2%
0.32
US$12,940 		40,000 -0.2% 0.32 US$12,940
2022-04-13 2022-04-12 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.34
US$6,700 		20,000 -0.1% 0.34 US$6,700
2022-04-13 2022-04-12 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.32
US$25,000 		78,125 -0.4% 0.32 US$25,000
2022-04-13 2022-04-11 PlS Planned sale
1.8
Hoffman Steve
Non-Executive Director Large shareholder
78,125 -0.4%
0.31
US$24,219 		78,125 -0.4% 0.31 US$24,219
2022-04-04 2022-04-04 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.35
US$7,004 		20,000 -0.1% 0.35 US$7,004
2022-03-30 2022-03-29 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.36
US$27,805 		78,125 -0.4% 0.36 US$27,805
2022-03-30 2022-03-28 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.34
US$26,773 		78,125 -0.4% 0.34 US$26,773
2022-03-29 2022-03-28 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.35
US$6,900 		20,000 -0.1% 0.35 US$6,900
2022-03-21 2022-03-21 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.33
US$6,580 		20,000 -0.1% 0.33 US$6,580
2022-03-14 2022-03-14 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.30
US$5,924 		20,000 -0.1% 0.30 US$5,924
2022-03-14 2022-03-11 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.31
US$24,219 		78,125 -0.4% 0.31 US$24,219
2022-03-14 2022-03-10 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.31
US$24,219 		78,125 -0.4% 0.31 US$24,219
2022-03-08 2022-03-07 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.29
US$5,840 		20,000 -0.1% 0.29 US$5,840
2022-03-01 2022-02-28 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.31
US$6,118 		20,000 -0.1% 0.31 US$6,118
2022-02-28 2022-02-25 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.30
US$23,438 		78,125 -0.4% 0.30 US$23,438
2022-02-28 2022-02-24 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.29
US$22,656 		78,125 -0.4% 0.29 US$22,656
2022-02-23 2022-02-22 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.32
US$6,464 		20,000 -0.1% 0.32 US$6,464
2022-02-22 2022-02-17 B Purchase
1.2
Van Tornout Jan M

Acting Chief Medical Officer

Officer
7,022 +250.0%
0.36
US$2,528 		7,022 +250.0% 0.36 US$2,528
2022-02-16 2022-02-15 B Purchase
2.7
Biehl James

Chief Legal Officer

Officer
20,000 +23.5%
0.34
US$6,800 		20,000 +23.5% 0.34 US$6,800
2022-02-14 2022-02-14 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.33
US$6,530 		20,000 -0.1% 0.33 US$6,530
2022-02-09 2022-02-08 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.36
US$28,125 		78,125 -0.4% 0.36 US$28,125
2022-02-09 2022-02-07 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.36
US$28,125 		78,125 -0.4% 0.36 US$28,125
2022-02-08 2022-02-07 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.36
US$7,124 		20,000 -0.1% 0.36 US$7,124
2022-01-31 2022-01-31 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.34
US$6,714 		20,000 -0.1% 0.34 US$6,714
2022-01-27 2022-01-26 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.34
US$26,562 		78,125 -0.4% 0.34 US$26,562
2022-01-27 2022-01-25 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.51
US$39,844 		78,125 -0.4% 0.51 US$39,844
2022-01-25 2022-01-24 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.52
US$10,400 		20,000 -0.1% 0.52 US$10,400
2022-01-21 2022-01-20 S Sale
3.7
Demurjian Michael
Large shareholder
320 -0.0%
0.59
US$189 		320 -0.0% 0.59 US$189
2022-01-10 2022-01-10 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.60
US$11,942 		20,000 -0.1% 0.60 US$11,942
2022-01-07 2022-01-06 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.62
US$48,438 		78,125 -0.4% 0.62 US$48,438
2022-01-07 2022-01-05 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.66
US$51,562 		78,125 -0.4% 0.66 US$51,562
2022-01-03 2022-01-03 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.64
US$12,724 		20,000 -0.1% 0.64 US$12,724
2021-12-21 2021-12-21 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.70
US$14,020 		20,000 -0.1% 0.70 US$14,020
2021-12-20 2021-12-17 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.70
US$54,688 		78,125 -0.4% 0.70 US$54,688
2021-12-20 2021-12-16 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.72
US$56,250 		78,125 -0.4% 0.72 US$56,250
2021-12-14 2021-12-13 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.75
US$14,912 		20,000 -0.1% 0.75 US$14,912
2021-12-08 2021-12-07 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.73
US$14,690 		20,000 -0.1% 0.73 US$14,690
2021-12-06 2021-12-03 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.72
US$56,250 		78,125 -0.4% 0.72 US$56,250
2021-12-06 2021-12-02 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.75
US$14,962 		20,000 -0.1% 0.75 US$14,962
2021-12-06 2021-12-02 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.72
US$56,250 		78,125 -0.4% 0.72 US$56,250
2021-12-01 2021-11-30 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.4%
0.72
US$56,250 		78,125 -0.4% 0.72 US$56,250
2021-12-01 2021-11-29 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.3%
0.74
US$57,812 		78,125 -0.3% 0.74 US$57,812
2021-11-29 2021-11-22 S Sale
3.7
Demurjian Michael
Large shareholder
9,380 -0.0%
0.80
US$7,531 		9,380 -0.0% 0.80 US$7,531
2021-11-18 2021-11-17 S Sale
3.7
Demurjian Michael
Large shareholder
20,000 -0.1%
0.91
US$18,258 		20,000 -0.1% 0.91 US$18,258
2021-11-17 2021-11-16 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.3%
0.92
US$71,875 		78,125 -0.3% 0.92 US$71,875
2021-11-17 2021-11-15 PlS Planned sale
1.8
Hoffman Steve

Chief Science Officer

Executive Director Large shareholder
78,125 -0.3%
0.92
US$71,875 		78,125 -0.3% 0.92 US$71,875
Explore more

More insider trading research around Tyme Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America